Apple jumped 5.8%, outpacing other megacap stocks in premarket trading after the iPhone maker unveiled a record $110 billion share buyback program and beat modest expectations for quarterly results and forecast. Amgen climbed 13.5% as the biotechnology firm said it was very encouraged after completing an interim analysis of its mid-stage study of experimental weight-loss drug MariTide and as it reported first-quarter earnings. Sentiment also remained upbeat as investors weighed the U.S. Federal Reserve's more dovish-than-expected interest rate guidance in its latest policy meeting, causing U.S. stocks to rally on Thursday.
Hostmore said on Friday that 2023 was a “transitional year” as it sought to put its finances back on a strong footing.